LEUNG GABRIEL (CIK 1236183) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy NVCR (11,610 shares), Sell NVCR (2,945 shares), Buy NVCR (11,215 shares), Sell NVCR (999 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | NovoCure Ltd (NVCR) | Director | Buy | 11,610 | $0 |
| 2026-06-03 | NovoCure Ltd (NVCR) | Director | Sell | 2,945 | $46,443 |
| 2025-06-06 | NovoCure Ltd (NVCR) | Director | Buy | 11,215 | $0 |
| 2025-06-04 | NovoCure Ltd (NVCR) | Director | Sell | 999 | $17,293 |
来源：SEC Form 4 申报文件 · 截至 2026-06-05